Solventum Corp (SOLV) Receives Hold Rating from Jefferies
Jefferies initiates coverage on Solventum Corp (SOLV) with a Hold rating.
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 22,000 full-time employees. The company went IPO on 2024-03-26. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Solventum Corp.
Last Updated: Dec 11, 2025, 11:30 PM · Source: Finnhub.io
Jefferies initiates coverage on Solventum Corp (SOLV) with a Hold rating.
BTIG has upgraded Solventum Corp (SOLV) to Buy from Neutral, reflecting improved outlook.
UBS initiates coverage on Solventum Corp (SOLV) with a Neutral rating.
Solventum Corp (SOLV) exceeds Q3 2025 earnings expectations.